Episodes
Friday May 19, 2023
E67: Who is Immunocore? Guest, Dr. Dar
Friday May 19, 2023
Friday May 19, 2023
A Cure in Sight is joined on The Eye Believe Podcast by Dr. Mohammed Dar, who is the Chief Medical Officer of Immunocore. Tune in to learn more!
In this brief discussion, Dr. Dar shares the origin and history of Immunocore, how they got started, and how their field came to include uveal melanoma.
To access the lists of currently recruiting clinical trials relevant to uveal melanoma, head to clinicaltrials.gov and search uveal melanoma.
Thank you again to Immunocore for their continued work for patients with rare diseases like Uveal Melanoma.
ANNOUNCEMENTS:
5K SITES ARE OPEN FOR REGISTRATION NEAR YOU! Start your team and bring your community to get involved!
June 10, Minneapolis, MN
https://bit.ly/3o5Mwr2
June 11, Philly, PA
https://bit.ly/3U4hsUH
July 8, Seattle, WA
https://bit.ly/3TTgvP3
July 15, Palo Alto, CA
https://bit.ly/3lRFi9D
August 6, NYC/Brooklyn/Jersey area
September 23, Denver, CO
https://runsignup.com/Race/CO/Denver/LookinForACureDenver
Head to our site to register for a 5K Lookin’ for a Cure near you for the remainder of the year!!
www.lookinforacure.org
Stay tuned for registration announcements and hotel registration for the Eye Believe Survivorship Seminar happening in Seattle, WA, Sept 8-9, 2023!
Subscribe to the newsletter to stay in the know
Newsletter link
Email contact@acureinsight.org for questions regarding any upcoming events!
*********
Be sure to follow us on Facebook, Twitter, Linked In, or Instagram @acureinsight, for more stories, tips, research news, and ideas to help you navigate this journey with OM!
*A Cure in Sight is a 501c3 organization. All donations made can help fund our podcast to educate patients, fund research, aid patients, and more!
Donate $10 $15 $20 today to help A Cure in Sight in their quest to find a cure.
Contribute via PAYPAL OR VENMO or reach out directly to contact@acureinsight.org
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.